84 related articles for article (PubMed ID: 31053566)
1. Impact of Patient-Directed Cytology Results Correspondence Program on Follow-Up of High-Grade Pap Tests.
Tavasoli SM; Kane E; Kupets R
J Obstet Gynaecol Can; 2019 Oct; 41(10):1461-1469. PubMed ID: 31053566
[TBL] [Abstract][Full Text] [Related]
2. Follow-up of women with cervical cytological abnormalities showing atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion: a nationwide cohort study.
Sundström K; Lu D; Elfström KM; Wang J; Andrae B; Dillner J; Sparén P
Am J Obstet Gynecol; 2017 Jan; 216(1):48.e1-48.e15. PubMed ID: 27457115
[TBL] [Abstract][Full Text] [Related]
3. Do follow-up recommendations for abnormal Papanicolaou smears influence patient adherence?
Melnikow J; Chan BK; Stewart GK
Arch Fam Med; 1999; 8(6):510-4. PubMed ID: 10575390
[TBL] [Abstract][Full Text] [Related]
4. Cervical Screening and Colposcopy Management of Women Age 24 and Under.
Buick C; Jembere N; Wang L; Kupets R
J Obstet Gynaecol Can; 2020 Dec; 42(12):1518-1524. PubMed ID: 32988802
[TBL] [Abstract][Full Text] [Related]
5. HPV genotyping for triage of women with abnormal cervical cancer screening results: a multicenter prospective study.
Nakamura Y; Matsumoto K; Satoh T; Nishide K; Nozue A; Shimabukuro K; Endo S; Nagai K; Oki A; Ochi H; Morishita Y; Noguchi M; Yoshikawa H
Int J Clin Oncol; 2015 Oct; 20(5):974-81. PubMed ID: 25652908
[TBL] [Abstract][Full Text] [Related]
6. A Study of Pap Smears in HIV-Positive and HIV-Negative Women from a Tertiary Care Center in South India.
Gupta K; Philipose CS; Rai S; Ramapuram J; Kaur G; Kini H; Gv C; Adiga D
Acta Cytol; 2019; 63(1):50-55. PubMed ID: 30721904
[TBL] [Abstract][Full Text] [Related]
7. Human papilloma virus testing knowledge and attitudes among women attending colposcopy clinic with ASCUS/LGSIL pap smears.
Le T; Hicks W; Menard C; Boyd D; Hewson T; Hopkins L; Kee Fung MF
J Obstet Gynaecol Can; 2004 Sep; 26(9):788-92. PubMed ID: 15361273
[TBL] [Abstract][Full Text] [Related]
8. Sociodemographic factors associated with cervical cancer screening coverage and follow-up of high grade abnormal results in a population-based cohort.
Elit L; Saskin R; Raut R; Elliott L; Murphy J; Marrett L
Gynecol Oncol; 2013 Jan; 128(1):95-100. PubMed ID: 23085459
[TBL] [Abstract][Full Text] [Related]
9. Impact of invitation and reminder letters on cervical cancer screening participation rates in an organized screening program.
Tavasoli SM; Pefoyo AJ; Hader J; Lee A; Kupets R
Prev Med; 2016 Jul; 88():230-6. PubMed ID: 27143497
[TBL] [Abstract][Full Text] [Related]
10. Clinical practice variation and overtreatment risk in women with abnormal cervical cytology in the Netherlands: two-step versus see-and-treat approach.
Loopik DL; Siebers AG; Melchers WJG; Massuger LFAG; Bekkers RLM
Am J Obstet Gynecol; 2020 Apr; 222(4):354.e1-354.e10. PubMed ID: 31647895
[TBL] [Abstract][Full Text] [Related]
11. Performance measures related to colposcopy for canadian cervical cancer screening programs: identifying areas for improvement.
Decker KM; McLachlin CM; Lotocki R;
J Obstet Gynaecol Can; 2015 Mar; 37(3):245-251. PubMed ID: 26001871
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the diagnostic value of cervical cytology and HPV HR DNA testing for the diagnosis of low-grade and high-grade squamous intraepithelial lesions across different age groups.
Paluszkiewicz A; Pruski D; Iwaniec K; Kędzia W
Ginekol Pol; 2017; 88(3):141-146. PubMed ID: 28397203
[TBL] [Abstract][Full Text] [Related]
13. Improving adherence to screening follow-up among women with abnormal Pap smears: results from a large clinic-based trial of three intervention strategies.
Marcus AC; Crane LA; Kaplan CP; Reading AE; Savage E; Gunning J; Bernstein G; Berek JS
Med Care; 1992 Mar; 30(3):216-30. PubMed ID: 1538610
[TBL] [Abstract][Full Text] [Related]
14. Sociodemographic factors associated with cervical cancer screening and follow-up of abnormal results.
Elit L; Krzyzanowska M; Saskin R; Barbera L; Razzaq A; Lofters A; Yeritsyan N; Bierman A
Can Fam Physician; 2012 Jan; 58(1):e22-31. PubMed ID: 22267636
[TBL] [Abstract][Full Text] [Related]
15. Repeat pap testing and colposcopic biopsies in the underserved.
Trivers KF; Benard VB; Eheman CR; Royalty JE; Ekwueme DU; Lawson HW
Obstet Gynecol; 2009 Nov; 114(5):1049-1056. PubMed ID: 20168106
[TBL] [Abstract][Full Text] [Related]
16. HPV-ISH-Negative Invasive Cervical Squamous Cell Carcinoma: Histologic and Pap Test Results.
Alexander C; White M; Maleki Z; Rodriguez EF
Acta Cytol; 2019; 63(5):417-423. PubMed ID: 31195388
[TBL] [Abstract][Full Text] [Related]
17. Is a liquid-based cytology more sensitive than a conventional Pap smear?
Sigurdsson K
Cytopathology; 2013 Aug; 24(4):254-63. PubMed ID: 23331613
[TBL] [Abstract][Full Text] [Related]
18. Are there flaws in the follow-up of women with low-grade cervical dysplasia in Ontario?
Kupets R; Lu Y; Vicus D; Paszat L;
J Obstet Gynaecol Can; 2014 Oct; 36(10):892-899. PubMed ID: 25375302
[TBL] [Abstract][Full Text] [Related]
19. Colposcopic episodes of care: referral, treatment, follow-up, and exit patterns of care for women with abnormal pap smears.
Kupets R; Lu Y; Vicus D; Paszat L;
J Obstet Gynaecol Can; 2014 Dec; 36(12):1079-1084. PubMed ID: 25668043
[TBL] [Abstract][Full Text] [Related]
20. Women's Behaviors Toward Mammogram and Pap Test: Opportunities to Increase Cervical Cancer Screening Participation Rates among Older Women.
Tavasoli SM; Kane E; Chiarelli AM; Kupets R
Womens Health Issues; 2018; 28(1):42-50. PubMed ID: 29174212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
